ArticleMedicinal chemistry (Shariqah (United Arab Emirates))2026

Novel Pyrrolopyrimidines as Inhibitors of CLK4 and HER2: Targeting Promising Anticancer Pathways.

Jonathan Gries et al.PubMed ↗Publisher ↗

No numbers read from the abstract.